NPR logo

Johnson & Johnson Makes It Largest Acquisition

  • Download
  • <iframe src="https://www.npr.org/player/embed/135760785/135760767" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Johnson & Johnson Makes It Largest Acquisition

Business

Johnson & Johnson Makes It Largest Acquisition

Johnson & Johnson Makes It Largest Acquisition

  • Download
  • <iframe src="https://www.npr.org/player/embed/135760785/135760767" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Johnson & Johnson announced it is buying Synthes, a company that makes orthopedic devices, for $21.3 billion. Johnson and Johnson sees a growing market for orthopedic products. An aging population means an increased demand for hip and knee replacements, as well as the screws and plates needed for these surgeries.

STEVE INSKEEP, host:

NPR's business news starts with a medical merger.

(Soundbite of music)

INSKEEP: Johnson & Johnson is making its largest acquisition ever. The company said today that it's buying a company that makes orthopedic devices called Synthes for $21 billion. Johnson & Johnson sees a growing market for orthopedic products. An aging population means an increased demand for hip and knee replacements, as well as the screws and plates needed for those surgeries.

Combining Synthes with Johnson & Johnson's existing medical device business would, by one estimate, give the company more than a quarter of the market for such devices.

Copyright © 2011 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.

We no longer support commenting on NPR.org stories, but you can find us every day on Facebook, Twitter, email, and many other platforms. Learn more or contact us.